Medpace Holdings Inc (OQ:MEDP)
Business Focus: Biotechnology & Medical Research
Mar 28, 2024 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results.
Feb 12, 2024 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2023.
Jan 03, 2024 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 12, 2024
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2023 financial results after the market close on Monday, February 12, 2024. The Company will host a conference call the following morning, Tuesday, February 13, 2024, at 9:00 a.m. ET to discuss these results.
Oct 23, 2023 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2023 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2023.
Sep 26, 2023 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2023 Financial Results on October 23, 2023
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2023 financial results after the market close on Monday, October 23, 2023. The Company will host a conference call the following morning, Tuesday, October 24, 2023, at 9:00 a.m. ET to discuss these results.
Jul 24, 2023 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2023 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2023.
Jul 05, 2023 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2023 Financial Results on July 24, 2023
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2023 financial results after the market close on Monday, July 24, 2023. The Company will host a conference call the following morning, Tuesday, July 25, 2023, at 9:00 a.m. ET to discuss these results.
Apr 24, 2023 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2023 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2023.
Mar 28, 2023 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the following morning, Tuesday, April 25, 2023, at 9:00 a.m. ET to discuss these results.
Feb 13, 2023 04:56 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2022.
Jan 04, 2023 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2022 financial results after the market close on Monday, February 13, 2023. The Company will host a conference call the following morning, Tuesday, February 14, 2023, at 9:00 a.m. ET to discuss these results.
Oct 24, 2022 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2022 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2022.
Sep 27, 2022 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2022 Financial Results on October 24, 2022
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2022 financial results after the market close on Monday, October 24, 2022. The Company will host a conference call the following morning, Tuesday, October 25, 2022, at 9:00 a.m. ET to discuss these results.
Jul 25, 2022 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2022 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2022.
Jul 07, 2022 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2022 Financial Results on July 25, 2022
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2022 financial results after the market close on Monday, July 25, 2022. The Company will host a conference call the following morning, Tuesday, July 26, 2022, at 9:00 a.m. ET to discuss these results.
Apr 25, 2022 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2022 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2022.
Mar 23, 2022 04:32 pm ET
Medpace Donation to Matthew 25: Ministries Funds Delivery of Relief Supplies to Ukraine
Medpace (MEDP), a global clinical research organization (CRO), has partnered with Matthew 25: Ministries, a humanitarian and disaster relief organization, to fund aid shipments to Ukraine and surrounding areas. The contribution will facilitate shipping and distribution of critically needed aid with an estimated value above $2.5 million. It will help hundreds of thousands of people in need in Ukraine and the surrounding areas.
Mar 17, 2022 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2022 Financial Results on April 25, 2022
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2022 financial results after the market close on Monday, April 25, 2022. The Company will host a conference call the following morning, Tuesday, April 26, 2022, at 9:00 a.m. ET to discuss these results.
Feb 14, 2022 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2021.
Jan 04, 2022 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 14, 2022
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2021 financial results after the market close on Monday, February 14, 2022. The Company will host a conference call the following morning, Tuesday, February 15, 2022, at 9:00 a.m. ET to discuss these results.
Oct 25, 2021 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2021 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2021.
Sep 07, 2021 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2021 Financial Results on October 25, 2021
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2021 financial results after the market close on Monday, October 25, 2021. The Company will host a conference call the following morning, Tuesday, October 26, 2021, at 9:00 a.m. ET to discuss these results.
Aug 30, 2021 04:05 pm ET
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference:
Jul 26, 2021 04:15 pm ET
Medpace Holdings, Inc. Announces Senior Leadership Changes
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced the appointment of Jesse Geiger as president and Kevin Brady as chief financial officer, effective August 1, 2021. August Troendle will continue to serve as Medpace’s chairman and chief executive officer.
Jul 26, 2021 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2021 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2021.
May 27, 2021 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2021 Financial Results on July 26, 2021
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2021 financial results after the market close on Monday, July 26, 2021. The Company will host a conference call the following morning, Tuesday, July 27, 2021, at 9:00 a.m. ET to discuss these results.
May 18, 2021 04:05 pm ET
Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference:
Apr 26, 2021 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2021 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2021.
Mar 10, 2021 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2021 Financial Results on April 26, 2021
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2021 financial results after the market close on Monday, April 26, 2021. The Company will host a conference call the following morning, Tuesday, April 27, 2021, at 9:00 a.m. ET to discuss these results.
Feb 15, 2021 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2020.
Jan 05, 2021 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 15, 2021
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2020 financial results after the market close on Monday, February 15, 2021. The Company will host a conference call the following morning, Tuesday, February 16, 2021, at 9:00 a.m. ET to discuss these results.
Oct 29, 2020 04:05 pm ET
Medpace Holdings, Inc. to Present at the Credit Suisse Healthcare Conference
Credit Suisse Healthcare Conference
Date: Tuesday, November 10, 2020
Presentation: 9:30 a.m. ET
Speakers: August Troendle, President & Chief Executive Officer, Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations, and Kevin Brady, Executive Director of Finance
Oct 26, 2020 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2020 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2020.
Sep 02, 2020 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2020 Financial Results on October 26, 2020
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2020 financial results after the market close on Monday, October 26, 2020. The Company will host a conference call the following morning, Tuesday, October 27, 2020, at 9:00 a.m. ET to discuss these results.
Aug 27, 2020 04:05 pm ET
Medpace Holdings, Inc. to Present at Baird's Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September:
Jul 27, 2020 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2020 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2020.
May 26, 2020 04:05 pm ET
Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following two investor conferences in June:
May 18, 2020 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2020 Financial Results on July 27, 2020
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2020 financial results after the market close on Monday, July 27, 2020. The Company will host a conference call the following morning, Tuesday, July 28, 2020, at 9:00 a.m. ET to discuss these results.
Apr 28, 2020 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2020 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2020.
Apr 03, 2020 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2020 Financial Results on April 28, 2020
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced that it will report its first quarter 2020 financial results after the market close on Tuesday, April 28, 2020. The Company will host a conference call the following morning, Wednesday, April 29, 2020, at 9:00 a.m. ET to discuss these results.
Feb 24, 2020 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2019.
Jan 14, 2020 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2019 Financial Results on February 24, 2020
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2019 financial results after the market close on Monday, February 24, 2020. The Company will host a conference call the following morning, Tuesday, February 25, 2020, at 9:00 a.m. ET to discuss these results.
Oct 31, 2019 04:00 pm ET
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in November:
Oct 28, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2019.
Sep 24, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2019 Financial Results on October 28, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2019 financial results after the market close on Monday, October 28, 2019. The Company will host a conference call the following morning, Tuesday, October 29, 2019, at 9:00 a.m. ET to discuss these results.
Aug 13, 2019 04:05 pm ET
Medpace Holdings, Inc. to Present at Baird Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September:
Jul 29, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2019.
Jun 25, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2019 Financial Results on July 29, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2019 financial results after the market close on Monday, July 29, 2019. The Company will host a conference call the following morning, Tuesday, July 30, 2019, at 9:00 a.m. ET to discuss these results.
May 21, 2019 04:05 pm ET
Medpace Holdings, Inc. to Present at Jefferies 2019 Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
that it will present at the following investor conference in June:
Apr 29, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
financial results for the first quarter ended March 31, 2019.
Apr 08, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2019 Financial Results on April 29, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its first quarter 2019 financial results after the market
close on Monday, April 29, 2019. The Company will host a conference call
the following morning, Tuesday, April 30, 2019, at 8:30 a.m. ET to
discuss these results.
Feb 25, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
financial results for the fourth quarter and full year ended December
31, 2018.
Feb 07, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on February 25, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its fourth quarter and fiscal year 2018 financial results
after the market close on Monday, February 25, 2019. The Company will
host a conference call the following morning, Tuesday, February 26,
2019, at 9:00 a.m. ET to discuss these results.
Feb 05, 2019 07:55 am ET
Analysis: Positioning to Benefit within Xylem, Integer, Medpace, Comstock Resources, Marriott Vacations Worldwide, and Big 5 Sporting Goods — Research Highlights Growth, Revenue, and Consolidated Resu
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Xylem Inc. (NYSE:XYL), Integer Holdings Corporation (NYSE:ITGR),...
Dec 21, 2018 05:15 pm ET
Medpace Holdings Set to Join S&P SmallCap 600
NEW YORK, Dec. 21, 2018 /PRNewswire/ -- Medpace Holdings Inc. (NASD: MEDP) will replace Green Bancorp Inc. (NASD: GNBC) in the S&P SmallCap 600 effective prior to the open of trading on Wednesday, January 2, 2019. S&P SmallCap 600 constituent Veritex Holdings Inc. (NASD: VBTX) is acquiring Green Bancorp in a deal expected to be completed soon pending final conditions.
Nov 01, 2018 04:05 pm ET
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
that it will present at the following investor conference in November:
Nov 01, 2018 08:50 am ET
Detailed Research: Economic Perspectives on Watsco, T-Mobile US, Medpace, eHealth, AllianceBernstein Holding, and Limelight Networks — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Watsco, Inc. (NYSE:WSO), T-Mobile US, Inc. (NASDAQ:TMUS), Medpace...
Oct 29, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
financial results for the third quarter ended September 30, 2018.
Oct 10, 2018 07:35 am ET
Report: Developing Opportunities Within Apollo Investment, Ladder Capital, Medpace, MPLX LP, Silicon Laboratories, and Protagonist Therapeutics — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Apollo Investment Corporation (NASDAQ:AINV), Ladder Capital Corp...
Oct 03, 2018 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2018 Financial Results on October 29, 2018
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its third quarter 2018 financial results after the market
close on Monday, October 29, 2018. The Company will host a conference
call the following morning, Tuesday, October 30, 2018, at 9:00 a.m. ET
to discuss these results.
Aug 22, 2018 08:15 pm ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced the
pricing of the previously announced secondary offering of 5,224,997
shares of its common stock by investment funds affiliated with Cinven
Capital Management (V) General Partner Limited (the “Selling
Shareholder”) at a public offering price of $55.50 per share. The
offering consists entirely of secondary shares of common stock to be
sold by the Selling Shareholder. Medpace will not receive any proceeds
from the sale of the shares of common stock by the Selling Shareholder.
Aug 22, 2018 04:44 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a
secondary offering of 5,224,997 shares of its common stock by investment
funds affiliated with Cinven Capital Management (V) General Partner
Limited (the “Selling Shareholder”). The offering consists entirely of
secondary shares of common stock to be sold by the Selling Shareholder.
Medpace will not receive any proceeds from the sale of the shares of
common stock by the Selling Shareholder.
Aug 15, 2018 04:30 pm ET
Medpace Holdings, Inc. to Present at Baird Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
that it will present at the following investor conference in September:
Aug 07, 2018 08:15 pm ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced the
pricing of the previously announced secondary offering of 4,500,000
shares of its common stock by investment funds affiliated with Cinven
Capital Management (V) General Partner Limited (the “Selling
Shareholder”) at a public offering price of $55.00 per share. In
addition, the Selling Shareholder has granted the underwriter a 30-day
option to purchase up to an additional 675,000 shares of common stock
from the Selling Shareholder. The offering consists entirely of
secon
Aug 07, 2018 04:33 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a
secondary offering of 4,500,000 shares of its common stock by investment
funds affiliated with Cinven Capital Management (V) General Partner
Limited (the “Selling Shareholder”). In addition, the Selling
Shareholder has granted the underwriter a 30-day option to purchase up
to an additional 675,000 shares of common stock from the Selling
Shareholder. The offering consists entirely of secondary shares of
common stock to be sold by the Selling Shareholder. Medpace will not
r
Aug 01, 2018 08:15 am ET
New Research Coverage Highlights Brunswick, Liberty Global, LaSalle Hotel Properties, Denny's, Medpace, and eHealth — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Brunswick Corporation (NYSE:BC), Liberty Global PLC (NASDAQ:LBTYA),...
Jul 30, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
financial results for the second quarter ended June 30, 2018.
Jul 11, 2018 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2018 Financial Results on July 30, 2018
To participate in the conference call, dial 800-219-7113 (domestic) or
574-990-1030 (international) using the passcode 7865703.
Jun 12, 2018 06:30 am ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced the
pricing of the previously announced secondary offering of 3,000,000
shares of its common stock by investment funds affiliated with Cinven
Capital Management (V) General Partner Limited (the “Selling
Shareholder”) at a public offering price of $42.25 per share. The
offering consists entirely of secondary shares of common stock to be
sold by the Selling Shareholder. Medpace will not receive any proceeds
from the sale of the shares of common stock by the Selling Shareholder.
Jun 11, 2018 04:28 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a
secondary offering of 3,000,000 shares of its common stock by investment
funds affiliated with Cinven Capital Management (V) General Partner
Limited (the “Selling Shareholder”). The offering consists entirely of
secondary shares of common stock to be sold by the Selling Shareholder.
Medpace will not receive any proceeds from the sale of the shares of
common stock by the Selling Shareholder.
May 24, 2018 04:05 pm ET
Medpace Holdings, Inc. to Present at Jefferies Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
that it will present at the following investor conference in June:
May 21, 2018 07:35 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within South Jersey Industries, SITO Mobile, Ormat Technologies, Redwood Trust, Medpace, and Meridian — New Research Emphasizes Economic Gr
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of South Jersey Industries, Inc. (NYSE:SJI), SITO Mobile, Ltd. (NASDAQ:SITO),...
May 02, 2018 04:30 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a
secondary offering of 3,000,000 shares of its common stock by investment
funds affiliated with Cinven Capital Management (V) General Partner
Limited (the “Selling Shareholder”). The offering consists entirely of
secondary shares of common stock to be sold by the Selling Shareholder.
Medpace will not receive any proceeds from the sale of the shares of
common stock by the Selling Shareholder.
Apr 30, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
financial results for the first quarter ended March 31, 2018.
Apr 27, 2018 05:25 pm ET
Medpace Holdings, Inc. to Report First Quarter 2018 Financial Results on April 30, 2018
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its first quarter 2018 financial results after the market
close on Monday, April 30, 2018. The Company will host a conference call
the following morning, Tuesday, May 1, 2018, at 9:00 a.m. ET to discuss
these results.
Mar 23, 2018 07:50 am ET
Consolidated Research: 2018 Summary Expectations for InfraREIT, Tower International, Medpace, Kaman, SEACOR, and Compass Diversified — Fundamental Analysis, Key Performance Indications
NEW YORK, March 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of InfraREIT, Inc. (NYSE:HIFR), Tower International, Inc....
Feb 27, 2018 07:00 am ET
Medpace Holdings, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Medpace Holdings, Inc. (NASDAQ: MEDP) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 9:00 AM Eastern Time.
Feb 26, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2017 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
financial results for the fourth quarter and full year ended December
31, 2017.
Feb 05, 2018 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on February 26, 2018
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its fourth quarter and fiscal year 2017 financial results
after the market close on Monday, February 26, 2018. The Company will
host a conference call the following morning, Tuesday, February 27,
2018, at 9:00 a.m. ET to discuss these results.
Jan 24, 2018 08:10 am ET
Analysis: Positioning to Benefit within Oritani Financial, Bio-Rad Laboratories, Compass Diversified, Q2, Medpace, and Engility — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Jan. 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Oritani Financial Corp. (NASDAQ:ORIT), Bio-Rad Laboratories,...
Nov 30, 2017 09:20 pm ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced the
pricing of the previously announced secondary offering of 4,000,000
shares of its common stock by investment funds affiliated with Cinven
Capital Management (V) General Partner Limited (the “Selling
Shareholder”) at a price to the public of $31.50 per share. In addition,
the Selling Shareholder has granted the underwriters a 30-day option to
purchase up to an additional 600,000 shares of common stock from the
Selling Shareholder. Medpace has agreed to repurchase from the
Nov 27, 2017 04:17 pm ET
Medpace Holdings, Inc. Announces Commencement of Proposed Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a
proposed secondary offering of 4,000,000 shares of its common stock by
investment funds affiliated with Cinven Capital Management (V) General
Partner Limited (the “Selling Shareholder”). In addition, the Selling
Shareholder has granted the underwriters a 30-day option to purchase up
to an additional 600,000 shares of common stock from the Selling
Shareholder. The offering consists entirely of secondary shares of
common stock to be sold by the Selling Shareholder. Medpace will no
Oct 30, 2017 04:30 pm ET
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced
that it will present at the following investor conference in November:
Oct 30, 2017 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2017 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
financial results for the third quarter ended September 30, 2017.
Oct 06, 2017 05:05 pm ET
Hillman Announces Key Management Change
CINCINNATI, Oct. 6, 2017 /PRNewswire/ -- The Hillman Companies, Inc. (NYSE-AMEX: HLM.PR) and The Hillman Group, Inc. (collectively, "Hillman" or the "Company") announced today that Robert (Rocky) Kraft will join Hillman as Chief Financial Officer and Treasurer on November 1, 2017.
Oct 04, 2017 04:01 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2017 Financial Results on October 30, 2017
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its third quarter 2017 financial results after the market
close on Monday, October 30, 2017. The Company will host a conference
call the following morning, Tuesday, October 31, 2017, at 9:00 a.m. ET
to discuss these results.
Sep 13, 2016 08:00 am ET
Citius Initiates Mino-Lok™ Phase 3 Trial
CRANFORD, N.J., Sept. 13, 2016 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated the pivotal Phase 3 clinical trial Mino-Lok™, an antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.